David Geffen School of Medicine at UCLA NICHD CRS

Site Details

LOCATION

Los Angeles, California

Get Directions

Site Type

CRS

CRS Coordinator

Michele Carter, RN

mfcarter@mednet.ucla.edu

CRS Leader

Jaime Deville, MD

jdeville@mednet.ucla.edu

Site Trials

COVID-19 and Mpox

Open and enrolling

A5418: A Randomized, Placebo-Controlled, Double-Blinded Trial of the Safety and Efficacy of Tecovirimat for the Treatment of Human Mpox Disease

A5418 (STOMP) is a study of tecovirimat (also known as TPOXX) for the treatment of human monkeypox virus (HMPXV) disease.